What is the difference between romilastin and loplastin?

Romiplostim and Romiplostim are actually different Chinese translations of the same drug. Their English names are both Romiplostim. The common trade name is Nplate, which is developed and produced by Amgen. This naming difference is mainly due to different translation standards or regional customs, and does not mean any substantial difference in drug ingredients, mechanism of action or uses.

Romiplostim is a recombinant fusion protein that is a thrombopoietin receptor agonist (TPO-RA). It simulates the natural TPO in the body and binds to the TPO receptor in the bone marrow, thereby stimulating megakaryocyte maturation and platelet production. It is widely used to treat patients with chronic immune thrombocytopenia (ITP), especially those who have failed to respond to corticosteroids, immunoglobulins, or splenectomy.

In terms of pharmacological effects, indications, administration methods and dosage management, Romigrastim is completely consistent with "Roplastin". The drug is usually injected subcutaneously once a week, and the dose is adjusted based on the patient's platelet levels to achieve and maintain appropriate platelet counts and reduce the risk of bleeding. It has a rapid onset of action and is one of the important choices for mid- and late-line treatment of ITP.
It should be noted that some Chinese medical literature or media use two different translations of "romiplostim" or "romiplostim" when referring to Romiplostim, which may confuse patients. In fact, this is just a difference at the translation level. Whether it is the name of the prescription drug, label instructions or clinical use, they all refer to the same drug. When patients obtain information or purchase medicines, they can avoid misunderstandings by confirming the English generic name "Romiplostim".
Reference: https://en.wikipedia.org/wiki/Romiplostim